Add to ORKGHighlights findings from a study of the use of phamacotherapies to treat substance abuse and the factors that affect their adoption by treatment organizations. Analyzes patterns by type of medication, type of organization, and accreditation
Objective. To investigate the impact of organizational characteristics, state and federal policies,...
Standardized patient placement criteria such as those developed by the American Society of Addiction...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...
Methadone and buprenorphine/naloxone are the two recommended pharmacotherapies for the treatment of ...
Methadone and buprenorphine/naloxone are the two recommended pharmacotherapies for the treatment of ...
To examine the influence of top managers\u27 characteristics on the adoption of buprenorphine for op...
helpful suggestions in the early stages of this research. 1ABSTRACT This paper examines policy, inst...
Studies consistently indicate a general lack of support for use of medications in the treatment of s...
Introduction Alcohol use disorders (AUDs) – mental and/or physical health diagnoses due to harmful a...
The Institute of Medicine noted that effective substance abuse treatment (SAT) programs integrate in...
Abstract Using medications in the treatment of substance abuse disorders has become as an important ...
Introduction: Community pharmacists in the United States routinely serve as intermediaries in the pr...
Pharmacotherapy includes a growing number of clinically effective medications for substance use diso...
The Institute of Medicine noted that effective substance abuse treatment (SAT) programs integrate in...
Community pharmacists in the United States have significant opportunity to engage in community-level...
Objective. To investigate the impact of organizational characteristics, state and federal policies,...
Standardized patient placement criteria such as those developed by the American Society of Addiction...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...
Methadone and buprenorphine/naloxone are the two recommended pharmacotherapies for the treatment of ...
Methadone and buprenorphine/naloxone are the two recommended pharmacotherapies for the treatment of ...
To examine the influence of top managers\u27 characteristics on the adoption of buprenorphine for op...
helpful suggestions in the early stages of this research. 1ABSTRACT This paper examines policy, inst...
Studies consistently indicate a general lack of support for use of medications in the treatment of s...
Introduction Alcohol use disorders (AUDs) – mental and/or physical health diagnoses due to harmful a...
The Institute of Medicine noted that effective substance abuse treatment (SAT) programs integrate in...
Abstract Using medications in the treatment of substance abuse disorders has become as an important ...
Introduction: Community pharmacists in the United States routinely serve as intermediaries in the pr...
Pharmacotherapy includes a growing number of clinically effective medications for substance use diso...
The Institute of Medicine noted that effective substance abuse treatment (SAT) programs integrate in...
Community pharmacists in the United States have significant opportunity to engage in community-level...
Objective. To investigate the impact of organizational characteristics, state and federal policies,...
Standardized patient placement criteria such as those developed by the American Society of Addiction...
OBJECTIVE:To identify the geographic, organisational, and payment correlates of buprenorphine and me...